Related Experiment Video

Updated: Aug 7, 2026

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR
07:24

Reduction in Left Ventricular Wall Stress and Improvement in Function in Failing Hearts using Algisyl-LVR

Published on: April 8, 2013

Left ventricular hypertrophy and antihypertensive therapy

W F Graettinger1, M A Weber

  • 1Veterans Affairs Medical Center, Long Beach, California.

American Family Physician
|August 1, 1992
PubMed

Insights

Left ventricular hypertrophy is common in hypertension and linked to serious cardiovascular events. Echocardiography can detect it, guiding treatment to prevent or reverse it with lifestyle changes and specific antihypertensive drugs.

Area of Science:

  • Cardiology
  • Hypertension Research
  • Diagnostic Imaging

Background:

  • Left ventricular hypertrophy (LVH) is prevalent in hypertensive individuals.
  • LVH presence correlates with increased risks of ventricular arrhythmias, myocardial infarction, heart failure, stroke, and cardiovascular mortality.
  • Echocardiography demonstrates higher sensitivity than electrocardiography for LVH detection.

Purpose of the Study:

  • To highlight the diagnostic utility of echocardiography in identifying left ventricular hypertrophy.
  • To emphasize the potential of identifying patients with borderline hypertension who may benefit from treatment.
  • To review therapeutic strategies for preventing or reversing LVH in hypertensive patients.

Main Methods:

  • Literature review of studies on left ventricular hypertrophy in hypertension.
  • Comparative analysis of diagnostic methods (echocardiography vs. electrocardiography).
  • Evaluation of the impact of weight reduction, drug therapy, and specific antihypertensive agents on LVH.

Main Results:

  • Echocardiography is more sensitive than electrocardiography for detecting LVH.
  • Echocardiographic detection of LVH in borderline hypertension can guide treatment decisions.
  • Weight reduction and certain antihypertensive drugs (beta-blockers, ACE inhibitors, calcium channel blockers, sympatholytics) can prevent or reverse LVH.

Conclusions:

  • Echocardiography is a valuable tool for diagnosing LVH in hypertensive patients.
  • Early detection and management of LVH are crucial for mitigating cardiovascular risks.
  • While evidence is limited, avoiding antihypertensive agents that may worsen LVH is advisable.

More Related Videos

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy08:34

Technique of Minimally Invasive Transverse Aortic Constriction in Mice for Induction of Left Ventricular Hypertrophy

Published on: September 25, 2017

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats07:41

A Model of Reverse Vascular Remodeling in Pulmonary Hypertension Due to Left Heart Disease by Aortic Debanding in Rats

Published on: March 1, 2022

Related Concept Videos

Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...